Goldina Erowele

Bio

Dr Erowele, clinical pharmacist and cofounder at CareNovateMag.com [http://www.carenovatemag.com], a free caregiving, social health and medication literacy web-resource. CareNovateMag.com provides timely, relevant and doable information to help family & professional caregivers, patients, families, healthcare extenders, consumers, seniors and most of all WOMEN with health, wellness and caregiving. CareNovateMag.com offers also offers instructive content through their twice weekly email communications and newsletter. Prior to pharmacy, Dr Erowele was a certified nursing assistant (CNA), passionate about helping the senior and elderly population. Attended Howard University College of Pharmacy and completed a year pharmacy practice residency program at the VAMC in Washington, D.C. Practiced at the Walter Reed Army Medical Center as a pharmacotherapy specialist in areas of geriatrics, formulary management, internal medicine, intensive care. While there, she had spearheaded, developed and implemented clinical pharmaceutical services.

As a clinical pharmacy specialist, she also manages & cordinates a multi-million hematology oncology pharmaceutical budget in a Houston, TX Hospital.  She serves as an adjunct professor at the College of Pharmacy & Health Sciences, where she lectures on various topics. She has authored and coauthored several pharmacy journals, book chapters and serves as a reviewer to multiple journals. She received the U.S. Army Commander’s Award for Civilian Service in 2005 and 2006 & the 2007 Mel Liter Clinical Pharmacy Award.  She is a member of the Kappa Epsilon Society (an honor society for pharmacy professions), a wife, sister, mom and a friend.

Specialties:

Affiliation:

  • CareNovateMag

Location:

Activity

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    WEDNESDAY, April 16, 2014 (HealthDay News) -- Dermatologists who receive free drug samples are more likely to give their patients prescriptions for expensive medicines, a new study says.

    Researchers looked at data on prescriptions for adult acne medications written in 2010 by dermatologis...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology/diabetes/metabolism:

    TUESDAY, April 15, 2014 (HealthDay News) -- Tanzeum (albiglutide) has been approved by the U.S. Food and Drug Administration to help control blood sugar in adults with type 2 diabetes.

    Some 24 million people in the United States have type 2 diabetes, which is more than 90 percent of all d...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology/diabetes/metabolism:

    TUESDAY, April 15, 2014 (HealthDay News) -- Millions of Americans with type 2 diabetes have a new treatment option with the U.S. Food and Drug Administration's approval Tuesday of a once-weekly injectable drug, Tanzeum.

    The FDA described Tanzeum (albiglutide) as a "glucagon-like peptide-...Full Article

  • Sharecare News
    Sharecare News posted a story about Pediatrics:

    MONDAY, April 14, 2014 (HealthDay News) -- Boys with autism were three times more likely to have been exposed to antidepressants known as SSRIs in the womb than typically developing children, according to new research.

    The new study also found that boys whose mothers took SSRIs -- drugs...Full Article

  • Sharecare News
    Sharecare News posted a story about Pharmacy:

    THURSDAY, April 10, 2014 (HealthDay News) -- No evidence exists to show that anti-flu medicines stockpiled by countries around the world protect people from the spread of flu or reduce related hospitalizations and complications, a new analysis contends.

    The report from the nonprofit Cochr...Full Article

  • Sharecare News
    Sharecare News posted a story about Cardiology:

    WEDNESDAY, April 9, 2014 (HealthDay News) -- A long-term study suggests that older people who use common prescription painkillers, including prescription-strength ibuprofen, may be increasing their risk for developing a type of irregular heartbeat called atrial fibrillation.

    Atrial fibri...Full Article

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    TUESDAY, April 8, 2014 (HealthDay News) -- An experimental cancer drug that activates the immune system has shown early promise for advanced cases of melanoma skin cancer, researchers report.

    The findings come from an early stage trial of just 31 patients. But experts were cautiously opti...Full Article

  • Sharecare News
    Sharecare News posted a story about Critical Care Medicine:

    MONDAY, April 7, 2014 (HealthDay News) -- A stay in an intensive care unit can lead to muscle weakness that continues to cause significant physical limitations for up to two years later, according to a new study.

    Researchers from the Johns Hopkins University Sch...Full Article

  • Sharecare News
    Sharecare News posted a story about Emergency Medicine:

    THURSDAY, April 3, 2014 (HealthDay News) -- People suffering a potentially fatal narcotic overdose now can receive lifesaving treatment from folks around them, using a new device just approved by the U.S. Food and Drug Administration.

    Evzio is a hand-held auto injector that delivers a sin...Full Article

  • Sharecare News
    Sharecare News posted a story about Cardiology:

    THURSDAY, April 3, 2014 (HealthDay News) -- A simple urine test for people with high blood pressure could help doctors determine if patients aren't taking their medication as directed or whether their body isn't respond to treatment, a new study suggests.

    Using this test, British research...Full Article

  • Sharecare News
    Sharecare News posted a story about Medical Toxicology:

    WEDNESDAY, April 2, 2014 (HealthDay News) -- There's been a big increase in prescriptions for powerful narcotic painkillers given to headache patients at hospital emergency departments, a new U.S. study finds.

    This increase has occurred even though guidelines from a number of medical grou...Full Article

  • Sharecare News
    Sharecare News posted a story about Neurology:

    WEDNESDAY, April 2, 2014 (HealthDay News) -- A handful of people taking a medication called Rebif to treat multiple sclerosis have developed a serious condition that causes blood clots to form in small blood vessels throughout the body.

    In a letter in the March 27 issue of the New Engl...Full Article

  • Sharecare News
    Sharecare News posted a story about Allergy / Immunology:

    WEDNESDAY, April 2, 2014 (HealthDay News) -- Oralair has been approved by the U.S. Food and Drug Administration as the first under-the-tongue treatment for certain grass allergies.

    The tablet contains freeze-dried pollen extracts of five grasses: Kentucky Blue Grass, Orchard, Perennial R...Full Article

  • Sharecare News
    Sharecare News posted a story about Allergy / Immunology:

    WEDNESDAY, April 2, 2014 (HealthDay News) -- Just in time for the spring allergy season, the U.S. Food and Drug Administration on Wednesday approved a new under-the-tongue pill to treat hay fever caused by certain grass pollens.

    Oralair is the first under-the-tongue allergen extract appr...Full Article

  • Sharecare News
    Sharecare News posted a story about Gerontology:

    WEDNESDAY, April 2, 2014 (HealthDay News) -- A record number of elderly Americans have living wills that explain their wishes for end-of-life medical care or appoint a surrogate medical decision maker, a new study finds.

    The percentage of seniors with living wills -- also called advance d...Full Article